Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Macquarie University
Clinical trial register · Australia

Clinical Trials in Macquarie University, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC16 AstraZeneca10 Janssen Research & Development, LLC9 Eli Lilly and Company4 Seagen, a wholly owned subsidiary of Pfizer3
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Macquarie University

51 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Darlinghurst, Garran, Heidelberg, Macquarie University, Melbourne, Perth, Port Macquarie
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Adelaide, Camperdown, Clayton, East Melbourne, Kurralta Park, Macquarie University, Murdoch, New Lambton Heights
2026-05-22
Recruiting
Eli Lilly and Company
Phase 1
30
Adelaide, Ivanhoe, Kogarah, Macquarie University, Melbourne
2026-05-21
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Macquarie University, Woolloongabba, Melbourne, Murdoch
2026-04-09
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Box Hill, Brisbane, Campbelltown, Heidelberg, Macquarie University, Perth, Randwick, St Albans
2025-12-12
Recruiting
AstraZeneca
Phase 3
420
Clayton, Macquarie University, Melbourne, Nedlands, Waratah
2025-11-11
Recruiting
AstraZeneca
Phase 2
435
Birtinya, Macquarie University, South Brisbane
2025-11-06
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Macquarie University, St Leonards, Heidelberg
2025-09-30
Recruiting
AstraZeneca
Phase 1/2
91
Macquarie University, Melbourne
2025-09-24
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Macquarie University, Brisbane, Ballarat Central, Heidelberg, Melbourne, Subiaco
2025-09-11
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
360
Macquarie University
2025-07-03
Recruiting
Perioperative Durvalumab With Neoadjuvant ddMVAC in Patients With Muscle-Invasive Bladder Cancer (NIAGARA-2)
NCT06960577Urinary Bladder Neoplasms, Immune Checkpoint Inhibitors, Methotrexate, Vinblastine
DrugsVinblastine·Methotrexate·Doxorubicin·Durvalumab
AstraZeneca
Phase 2
150
Chermside, Elizabeth Vale, Heidelberg, Hong Kong, Kogarah, Macquarie University, Murdoch, Port Macquarie
2025-05-15
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,440
Blacktown, Macquarie University, Greenslopes, Melbourne, Murdock
2025-05-13
Active, closed
Celgene
Phase 3
960
Campbelltown, Darlinghurst, Macquarie University, Port Macquarie, Wahroonga, Greenslopes, Southport, Adelaide
2025-03-13
Recruiting
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
NCT06833073Urinary Bladder Neoplasms, Non-Muscle Invasive Bladder Neoplasms, Carcinoma in Situ
DrugIntismeran autogene
Merck Sharp & Dohme LLC
Phase 2
308
Macquarie University, Perth
2025-03-11
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Macquarie University, Melbourne, Nedlands, Randwick
2024-12-30
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Heidelberg, Kogarah, Macquarie University, Nedlands
2024-11-27
Recruiting
AstraZeneca
Phase 3
1,018
Clayton, Darlinghurst, Garran, Heidelberg, Macquarie University, Nedlands
2024-08-07
Recruiting
GlaxoSmithKline
Phase 1
675
Blacktown, Macquarie University
2024-07-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,530
Macquarie University, Westmead, Brisbane, Frankston
2024-06-24
Recruiting
Merck Sharp & Dohme LLC
Phase 1/2
220
Macquarie University, Greenslopes, Melbourne
2024-05-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,200
Macquarie University, Westmead, Frankston, Murdoch
2024-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 2
272
Macquarie University, Westmead, Brisbane, Murdoch
2024-04-10
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
230
Macquarie University, Westmead, South Brisbane, Nedlands
2024-03-28
Active, closed
AbbVie
Observational
1,200
Blacktown, Macquarie University, South Brisbane, Kurralta Park, Woodville South, Clayton, Melbourne
2024-02-19
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,310
Dubbo, Macquarie University, Westmead, Brisbane, Melbourne
2023-12-31
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Macquarie University, Westmead, Brisbane, Clayton, Melbourne
2023-12-18
Active, closed
A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2
NCT06003231Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Endometrial Neoplasms, Head and Neck Neoplasms
DrugDisitamab Vedotin
Seagen, a wholly owned subsidiary of Pfizer
Phase 2
120
Camperdown, Macquarie University, Old Toongabie, Frankston, Blacktown
2023-11-14
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Concord, Darlinghurst, Macquarie University, North Ryde, Randwick, Brisbane, Chermside, Herston
2023-09-22
Active, closed
Janssen Research & Development, LLC
Phase 3
420
Macquarie University, Melbourne, South Brisbane
2023-08-31
Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
NCT05867251Advanced Solid Tumor, HR+/HER2- Breast Cancer, HR+, HER2-, Advanced Breast Cancer, CCNE1 Amplification
DrugsAVZO-021·Sacituzumab Govitecan·Ribociclib·Abemaciclib
Avenzo Therapeutics, Inc.
Phase 1/2
430
Macquarie University, Wollongong
2023-08-30
Recruiting
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer
NCT05818683Metastatic Castration-resistant Prostate Neoplasms, Metastatic Hormone-sensitive Prostate Cancer
DrugsJNJ-101556143·Lutetium Lu-177 vipivotide tetraxetan·Pasritamig·Cabazitaxel
Janssen Research & Development, LLC
Phase 1
300
Kurralta Park, Macquarie University, Melbourne, Woolloongabba
2023-04-26
Active, closed
Janssen Research & Development, LLC
Phase 3
1,135
Heidelberg, Macquarie University, Nedlands, South Brisbane
2023-03-23
Active, closed
Bellus Health Inc. - a GSK company
Phase 3
997
Coffs Harbour, Macquarie University, New Lambton Heights, St Leonards, Chermside, Adelaide, St Albans, Nedlands
2022-12-05
Active, closed
Janssen Research & Development, LLC
Phase 1
167
Macquarie University, Melbourne, Nedlands, Randwick
2022-08-18
Active, closed
Merck Sharp & Dohme LLC
Phase 1/2
60
Macquarie University, Westmead, Frankston, Nedlands
2022-08-10
Active, closed
Eli Lilly and Company
Phase 3
925
Camperdown, Coffs Harbour, Darlinghurst, Liverpool, Macquarie University, South Brisbane, Southport, Woolloongabba
2022-04-14
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,800
Blacktown, Macquarie University, North Tamworth, Brisbane, Elizabeth Vale, Heidelberg, Murdoch
2022-03-15
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
654
Camperdown, Macquarie University, Westmead, Adelaide, Bedford Park, Box Hill, Heidelberg, Subiaco
2022-03-07
Active, closed
AstraZeneca
Phase 3
148
Box Hill, Macquarie University
2021-10-28
Active, closed
Merck Sharp & Dohme LLC
Phase 3
808
Macquarie University, South Brisbane, Elizabeth Vale, Frankston
2021-04-21
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,688
Liverpool, Macquarie University, Elizabeth Vale, Clayton, Murdock
2021-04-14
Active, closed
Canadian Cancer Trials Group
Phase 3
250
Bowral, Gateshead, Gosford, Macquarie University, Nowra, Birtinya, Toowoomba, East Melbourne
2021-01-27
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Adelaide, Benowa, Birtinya, Brisbane, Darlinghurst, Hobart, Macquarie University, Malvern
2019-01-25
Active, closed
Eli Lilly and Company
Phase 2/3
393
Camperdown, Kogarah, Macquarie University, Randwick, Melbourne
2018-11-26
Active, closed
AstraZeneca
Phase 3
1,063
Brisbane, Elizabeth Vale, Macquarie University, Melbourne, Murdoch, South Brisbane
2018-11-16
Active, closed
AstraZeneca
Phase 3
1,246
Box Hill, Elizabeth Vale, Kogarah, Macquarie University, Murdoch, Orange, South Brisbane, St Albans
2018-09-27
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,500
Camperdown, Liverpool, Macquarie University, North Sydney, Orange, Port Macquarie, St Leonards, Waratah
2018-08-21
Active, closed
AbbVie
Phase 3
950
Macquarie University, South Brisbane, Southport, Clayton, Fitzroy Melbourne, Murdoch
2017-01-31
Active, closed
AstraZeneca
Phase 3
1,126
Box Hill, Elizabeth Vale, Macquarie University, St Leonards, Waratah
2015-11-02
Rows per page Showing 1–51 of 51
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/macquarie-university

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 51 of those studies with a site in Macquarie University.

How many clinical trials are recruiting in Macquarie University?

26 of the 51 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 24 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Macquarie University), 51 studies
PhaseStudiesRecruitingShare
Phase 3301358.8%
Phase 1/26411.8%
Phase 26411.8%
Phase 1539.8%
Phase 2/3325.9%
Observational102%

Most active sponsors

Lead sponsors with the most studies (Macquarie University)
Lead sponsorStudiesRecruiting
Merck Sharp & Dohme LLC1610
AstraZeneca106
Janssen Research & Development, LLC94
Eli Lilly and Company42
Seagen, a wholly owned subsidiary of Pfizer30
AbbVie20
Bristol-Myers Squibb22
Avenzo Therapeutics, Inc.11
Bellus Health Inc. - a GSK company10
Canadian Cancer Trials Group10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.